Preliminary evidence of ubiquitin proteasome system dysregulation in schizophrenia and bipolar disorder: Convergent pathway analysis findings from two independent samples

American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

Volumn 153, Issue 2, 2010, Pages 494-502

  Bousman, Chad A ^a   Chana, Gursharan ^a   Glatt, Stephen J ^b   Chandler, Sharon D ^a   Lucero, Ginger R ^a   Tatro, Erick ^a   May, Todd ^a   Lohr, James B ^a   Kremen, William S ^a,d   Tsuang, Ming T ^a,c,d   Everall, Ian P ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b State University of New York Upstate Medical University: College of Medicine   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

Author keywords

Biomarkers; Gene expression; Microarray; Mrna; Ubiquitin

Indexed keywords

MOOD STABILIZER; NEUROLEPTIC AGENT; PROTEASOME; UBIQUITIN;

ADULT; ANALYSIS; ARTICLE; BIPOLAR DISORDER; BLOOD; CLINICAL ARTICLE; COMPARATIVE STUDY; COMPUTER PROGRAM; CONTROLLED STUDY; FEMALE; GENE; GENE EXPRESSION; HISTORY; HUMAN; MALE; MICROARRAY ANALYSIS; PRIORITY JOURNAL; PSYCHOSIS; SAMPLE; SCHIZOPHRENIA; TAIWAN;

ADULT; BIPOLAR DISORDER; CASE-CONTROL STUDIES; FEMALE; GENE EXPRESSION REGULATION; HUMANS; MALE; MIDDLE AGED; MODELS, GENETIC; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTEASOME ENDOPEPTIDASE COMPLEX; PSYCHOTIC DISORDERS; RNA, MESSENGER; SCHIZOPHRENIA; SOFTWARE; TAIWAN; UBIQUITIN;

EID: 77349083055     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.31006     Document Type: Article

References (34)

1. Altar CA, Jurata LW, Charles V, Lemire A, Liu P, Bukhman Y, Young TA, Bullard J, Yokoe H, Webster MJ, Knable MB, Brockman JA. 2005. Deficient hippocampal neuron expression of proteasome, ubiquitin, and mitochondrial genes in multiple schizophrenia cohorts. Biol Psychiatry 58:85-96.
2. Bansal M, Belcastro V, Ambesi-Impiombato A, di Bernardo D. 2007. How to infer gene networks from expression profiles. Mol Syst Biol 3:78.
3. Bearden CE, Reus VI, Freimer NB. 2004. Why genetic investigation of psychiatric disorders is so difficult. Curr Opin Genet Dev 14:280-286.
4. Bowden NA, Weidenhofer J, Scott RJ, Schall U, Todd J, Michie PT, Tooney PA. 2006. Preliminary investigation of gene expression profiles in peripheral blood lymphocytes in schizophrenia. Schizophr Res 82:175-183.
5. Chana G, Glatt SJ, Everall IP, Tsuang MT. 2008. Blood and brain gene expression in major psychiatric disorders: A search for biomarkers. In: Turck CW (Ed.). Biomarkers for psychiatric disorders. New York: Springer.
6. Ciechanover A, Brundin P. 2003. The ubiquitin proteasome system in neurodegenerative diseases: Sometimes the chicken, sometimes the egg. Neuron 40:427-446.
7. Ciechanover A, Orian A, Schwartz AL. 2000. Ubiquitin-mediated proteolysis: Biological regulation via destruction. Bioessays 22:442-451.
8. Gladkevich A, Kauffman HF, Korf J. 2004. Lymphocytes as a neural probe: Potential for studying psychiatric disorders. Prog Neuropsychopharmacol Biol Psychiatry 28:559-576.
9. Gonzales J, Kemppainen J, Latham G, Goldrick M. 2005. Isolate RNA from white blood cells captured by a novel filter system. Ambion TechNotes 12:24-25.
10. Huang JT, Leweke FM, Oxley D, Wang L, Harris N, Koethe D, Gerth CW, Nolden BM, Gross S, Schreiber D, Reed B, Bahn S. 2006. Disease biomarkers in cerebrospinal fluid of patients with first-onset psychosis. PLoS Med 3:e428.
11. Huang JT, Leweke FM, Tsang TM, Koethe D, Kranaster L, GerthCW,Gross S, Schreiber D, Ruhrmann S, Schultze-Lutter F, Klosterkotter J, Holmes E, Bahn S. 2007. CSF metabolic and proteomic profiles in patients prodromal for psychosis. PLoS ONE 2:e756.
12. Konradi C, Eaton M, MacDonald ML, Walsh J, Benes FM, Heckers S. 2004. Molecular evidence for mitochondrial dysfunction in bipolar disorder. Arch Gen Psychiatry 61:300-308.
13. Lam YA, Pickart CM, Alban A, Landon M, Jamieson C, Ramage R, Mayer RJ, Layfield R. 2000. Inhibition of the ubiquitin-proteasome system in Alzheimer's disease. Proc Natl Acad Sci USA 97:9902-9906.
14. Liew CC. 1999. Method for the detection of gene transcripts in blood and uses thereof.
15. Merikangas KR, Akiskal HS, Angst J, Greenberg PE, Hirschfeld RM, Petukhova M, Kessler RC. 2007. Lifetime and 12-month prevalence of bipolar spectrum disorder in the national comorbidity survey replication. Arch Gen Psychiatry 64:543-552.
16. Middleton FA, Mirnics K, Pierri JN, Lewis DA, Levitt P. 2002. Gene expression profiling reveals alterations of specific metabolic pathways in schizophrenia. J Neurosci 22:2718-2729.
17. Middleton FA, Pato CN, Gentile KL, McGann L, Brown AM, Trauzzi M, Diab H, Morley CP, Medeiros H, Macedo A, Azevedo MH, Pato MT. 2005. Gene expression analysis of peripheral blood leukocytes from discordant sib-pairs with schizophrenia and bipolar disorder reveals points of convergence between genetic and functional genomic approaches. Am J Med Genet Part B 136B:12-25.
18. Mimmack ML, Ryan M, Baba H, Navarro-Ruiz J, Iritani S, Faull RL, McKenna PJ, Jones PB, Arai H, Starkey M, Emson PC, Bahn S. 2002. Gene expression analysis in schizophrenia: Reproducible up-regulation of several members of the apolipoprotein L family located in a high-susceptibility locus for schizophrenia on chromosome 22. Proc Natl Acad Sci USA 99:4680-4685.
19. Mirnics K, Levitt P, Lewis DA. 2006. Critical appraisal of DNA microarrays in psychiatric genomics. Biol Psychiatry 60:163-176.
20. Nurnberger JI Jr, Blehar MC, Kaufmann CA, York-Cooler C, Simpson SG, Harkavy-Friedman J, Severe JB, Malaspina D, Reich T. 1994. Diagnostic interview for genetic studies, rationale, unique features, and training. NIMH genetics initiative. Arch Gen Psychiatry 51:849-859; discussion 863-864.
21. Pospisil P, Iyer LK, Adelstein SJ, Kassis AI. 2006. A combined approach to data mining of textual and structured data to identify cancer-related targets. BMC Bioinformatics 7:354.
22. Prabakaran S, Swatton JE, Ryan MM, Huffaker SJ, Huang JT, Griffin JL, Wayland M, Freeman T, Dudbridge F, Lilley KS, Karp NA, Hester S, Tkachev D, Mimmack ML, Yolken RH, Webster MJ, Torrey EF, Bahn S. 2004. Mitochondrial dysfunction in schizophrenia: Evidence for compromised brain metabolism and oxidative stress. Mol Psychiatry 9: 684-697, 643.
23. Saha S, Chant D, McGrath J. 2008. Meta-analyses of the incidence and prevalence of schizophrenia: Conceptual and methodological issues. Int J Methods Psychiatr Res 17:55-61.
24. Schroeder A, Mueller O, Stocker S, Salowsky R, Leiber M, Gassmann M, Lightfoot S, Menzel W, Granzow M, Ragg T. 2006. The RIN: An RNA integrity number for assigning integrity values to RNA measurements. BMC Mol Biol 7:3.
25. Shimura H, Schlossmacher MG, Hattori N, Frosch MP, Trockenbacher A, Schneider R, Mizuno Y, Kosik KS, Selkoe DJ. 2001. Ubiquitination of a new form of alpha-synuclein by parkin from human brain: Implications for Parkinson's disease. Science 293:263-269.
26. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, Mesirov JP. 2005. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 102:15545-15550.
27. Sullivan PF, Fan C, Perou CM. 2006. Evaluating the comparability of gene expression in blood and brain. Am J Med Genet Part B 141B:261-268.
28. Tkachev D, Mimmack ML, Ryan MM, Wayland M, Freeman T, Jones PB, Starkey M, Webster MJ, Yolken RH, Bahn S. 2003. Oligodendrocyte dysfunction in schizophrenia and bipolar disorder. Lancet 362:798-805.
29. Tsuang MT, Nossova N, Yager T, Tsuang MM, Guo SC, Shyu KG, Glatt SJ, Liew CC. 2005. Assessing the validity of blood-based gene expression profiles for the classification of schizophrenia and bipolar disorder: A preliminary report. Am J Med Genet Part B 133B: 1-5.
30. Vawter MP, Barrett T, Cheadle C, Sokolov BP, Wood WH III, Donovan DM, Webster M, Freed WJ, Becker KG. 2001. Application of cDNA microarrays to examine gene expression differences in schizophrenia. Brain Res Bull 55:641-650.
31. Vawter MP, Crook JM, Hyde TM, Kleinman JE, Weinberger DR, Becker KG, Freed WJ. 2002. Microarray analysis of gene expression in the prefrontal cortex in schizophrenia: A preliminary study. Schizophr Res 58:11-20.
32. Vawter MP, Ferran E, Galke B, Cooper K, Bunney WE, Byerley W. 2004. Microarray screening of lymphocyte gene expression differences in a multiplex schizophrenia pedigree. Schizophr Res 67: 41-52.
33. Yao Y, Schroder J, Karlsson H. 2008. Verification of proposed peripheral biomarkers in mononuclear cells of individuals with schizophrenia. J Psychiatr Res 42:639-643.
34. Zvara A, Szekeres G, Janka Z, Kelemen JZ,Cimmer C, SanthaM,Puskas LG. 2005. Over-expression of dopamine D2 receptor and inwardly rectifying potassium channel genes in drug-naive schizophrenic peripheral blood lymphocytes as potential diagnostic markers. Dis Markers 21:61-69.